Literature DB >> 9795237

Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system.

V K Pestonjamasp1, S H Burstein.   

Abstract

The hypothesis that the capability of agents to mobilize arachidonic acid (AA) could predict increased anandamide (ANA) synthesis in a macrophage cell line has been examined. Lipopolysaccharide (LPS), platelet-activating factor (PAF) and cannabinoids such as Delta9-tetrahydrocannabinol (THC) and anandamide were all found to be agonists for the release of AA and led to increased ANA synthesis in RAW264.7 mouse macrophage cells. Nitric oxide, in contrast, stimulated AA release without raising ANA levels. ANA stimulation of its own synthesis indicates the existence of a positive feedback mechanism. The possible involvement of the CB2 receptor in THC-mediated AA release and ANA synthesis is addressed using the antagonist SR144528. ANA synthesis is also increased by the combination of calcium ionophore and indomethacin, suggesting that ANA is metabolized by a cyclooxygenase in this system. The data imply that ANA could play a role in the response of the immune system to cannabinoids and bacterial endotoxins and that AA mobilization is a predictor for increased ANA synthesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795237     DOI: 10.1016/s0005-2760(98)00110-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  24 in total

Review 1.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 2.  Endocannabinoids and immune regulation.

Authors:  Rupal Pandey; Khalida Mousawy; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Pharmacol Res       Date:  2009-04-07       Impact factor: 7.658

3.  Resolution of inflammation by N-arachidonoylglycine.

Authors:  Sumner H Burstein; Catherine A McQuain; Alonzo H Ross; Rebecca A Salmonsen; Robert E Zurier
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

4.  α2-Adrenoceptor agonist induces peripheral antinociception via the endocannabinoid system.

Authors:  Thiago Roberto Lima Romero; Marina Gomes Miranda E Castor; Cosimo Parrella; Fabiana Piscitelli; Vincenzo Di Marzo; Igor Dimitri Gama Duarte
Journal:  Pharmacol Rep       Date:  2020-01-10       Impact factor: 3.024

Review 5.  Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.

Authors:  William E Greineisen; Helen Turner
Journal:  Int Immunopharmacol       Date:  2010-02-25       Impact factor: 4.932

6.  Activation of CB1R Promotes Lipopolysaccharide-Induced IL-10 Secretion by Monocytic Myeloid-Derived Suppressive Cells and Reduces Acute Inflammation and Organ Injury.

Authors:  Jérémie Joffre; Che-Chung Yeh; Erika Wong; Mayuri Thete; Fengyun Xu; Ivana Zlatanova; Elliot Lloyd; Lester Kobzik; Matthieu Legrand; Judith Hellman
Journal:  J Immunol       Date:  2020-05-08       Impact factor: 5.422

Review 7.  Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.

Authors:  May Hamza; Raymond A Dionne
Journal:  Curr Mol Pharmacol       Date:  2009-01       Impact factor: 3.339

8.  2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.

Authors:  François Chouinard; Caroline Turcotte; Xiaochun Guan; Marie-Chantal Larose; Samuel Poirier; Line Bouchard; Véronique Provost; Louis Flamand; Nathalie Grandvaux; Nicolas Flamand
Journal:  J Leukoc Biol       Date:  2012-12-12       Impact factor: 4.962

Review 9.  Cannabinoids and neuroinflammation.

Authors:  Lisa Walter; Nephi Stella
Journal:  Br J Pharmacol       Date:  2004-02-02       Impact factor: 8.739

10.  Energy consumption by phospholipid metabolism in mammalian brain.

Authors:  A D Purdon; T A Rosenberger; H U Shetty; S I Rapoport
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.